Discontinued — last reported Q4 '25
Financing
Excise Tax Paid On Net Share Repurchase, Financing Activities
United Therapeutics Excise Tax Paid On Net Share Repurchase, Financing Activities remained flat by 0.0% to $1.25M in Q4 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementCash Flow Statement
SectionFinancing
CategoryCapital Allocation
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ4 2025Feb 25, 2026
How to read this metric
An increase signals higher volume of share repurchases, which may indicate management's confidence in the stock price or a strategy to return excess capital.
Detailed definition
Reflects the cash paid for excise taxes levied specifically on net share repurchases as required by regulatory tax frame...
Peer comparison
Common for US-based companies following recent tax legislation; peers with active buyback programs will show similar line items.
Metric ID:
financing_excise_tax_paid_on_net_share_repurchase_financ_334248Historical Data
10 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.25M | $1.25M | $1.25M | $1.25M |
| QoQ Change | — | — | — | — | — | — | — | +0.0% | +0.0% | +0.0% |
Range$0.00 – $1.25M
Current Streak3+ quarters growth
Excise Tax Paid On Net Share Repurchase, Financing Activities at Other Companies
Frequently Asked Questions
- What is United Therapeutics's excise tax paid on net share repurchase, financing activities?
- United Therapeutics (UTHR) reported excise tax paid on net share repurchase, financing activities of $1.25M in Q4 2025.
- What does excise tax paid on net share repurchase, financing activities mean?
- Cash paid for taxes triggered by share buyback activities.